Copyright Reports & Markets. All rights reserved.

Global Drug-Eluting Balloon Catheters Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Drug-Eluting Balloon Catheters Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Coronary Artery Disease Drug-Eluting Balloon Catheters
    • 1.3.3 Peripheral Vascular Disease Drug-Eluting Balloon Catheters
  • 1.4 Market Analysis by Use Scenario
    • 1.4.1 Overview: Global Drug-Eluting Balloon Catheters Consumption Value by Use Scenario: 2021 Versus 2025 Versus 2032
    • 1.4.2 In-Stent Restenosi
    • 1.4.3 De Novo
    • 1.4.4 Small Vessel
  • 1.5 Market Analysis by Balloon Platform Mechanics
    • 1.5.1 Overview: Global Drug-Eluting Balloon Catheters Consumption Value by Balloon Platform Mechanics: 2021 Versus 2025 Versus 2032
    • 1.5.2 Semi-/Compliant
    • 1.5.3 Non-compliant
    • 1.5.4 Other
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Drug-Eluting Balloon Catheters Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospitals and Clinics
    • 1.6.3 Ambulatory Surgical Centers
    • 1.6.4 Catheterization Laboratories
  • 1.7 Global Drug-Eluting Balloon Catheters Market Size & Forecast
    • 1.7.1 Global Drug-Eluting Balloon Catheters Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Drug-Eluting Balloon Catheters Sales Quantity (2021-2032)
    • 1.7.3 Global Drug-Eluting Balloon Catheters Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 B. Braun
    • 2.1.1 B. Braun Details
    • 2.1.2 B. Braun Major Business
    • 2.1.3 B. Braun Drug-Eluting Balloon Catheters Product and Services
    • 2.1.4 B. Braun Drug-Eluting Balloon Catheters Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 B. Braun Recent Developments/Updates
  • 2.2 Medtronic
    • 2.2.1 Medtronic Details
    • 2.2.2 Medtronic Major Business
    • 2.2.3 Medtronic Drug-Eluting Balloon Catheters Product and Services
    • 2.2.4 Medtronic Drug-Eluting Balloon Catheters Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Medtronic Recent Developments/Updates
  • 2.3 Boston Scientific
    • 2.3.1 Boston Scientific Details
    • 2.3.2 Boston Scientific Major Business
    • 2.3.3 Boston Scientific Drug-Eluting Balloon Catheters Product and Services
    • 2.3.4 Boston Scientific Drug-Eluting Balloon Catheters Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boston Scientific Recent Developments/Updates
  • 2.4 BD
    • 2.4.1 BD Details
    • 2.4.2 BD Major Business
    • 2.4.3 BD Drug-Eluting Balloon Catheters Product and Services
    • 2.4.4 BD Drug-Eluting Balloon Catheters Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 BD Recent Developments/Updates
  • 2.5 Yinyi Biotechnology
    • 2.5.1 Yinyi Biotechnology Details
    • 2.5.2 Yinyi Biotechnology Major Business
    • 2.5.3 Yinyi Biotechnology Drug-Eluting Balloon Catheters Product and Services
    • 2.5.4 Yinyi Biotechnology Drug-Eluting Balloon Catheters Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Yinyi Biotechnology Recent Developments/Updates
  • 2.6 Acotec
    • 2.6.1 Acotec Details
    • 2.6.2 Acotec Major Business
    • 2.6.3 Acotec Drug-Eluting Balloon Catheters Product and Services
    • 2.6.4 Acotec Drug-Eluting Balloon Catheters Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Acotec Recent Developments/Updates
  • 2.7 Philips
    • 2.7.1 Philips Details
    • 2.7.2 Philips Major Business
    • 2.7.3 Philips Drug-Eluting Balloon Catheters Product and Services
    • 2.7.4 Philips Drug-Eluting Balloon Catheters Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Philips Recent Developments/Updates
  • 2.8 Lepu Medical
    • 2.8.1 Lepu Medical Details
    • 2.8.2 Lepu Medical Major Business
    • 2.8.3 Lepu Medical Drug-Eluting Balloon Catheters Product and Services
    • 2.8.4 Lepu Medical Drug-Eluting Balloon Catheters Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Lepu Medical Recent Developments/Updates
  • 2.9 Eurocor
    • 2.9.1 Eurocor Details
    • 2.9.2 Eurocor Major Business
    • 2.9.3 Eurocor Drug-Eluting Balloon Catheters Product and Services
    • 2.9.4 Eurocor Drug-Eluting Balloon Catheters Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Eurocor Recent Developments/Updates
  • 2.10 MicroPort Medical
    • 2.10.1 MicroPort Medical Details
    • 2.10.2 MicroPort Medical Major Business
    • 2.10.3 MicroPort Medical Drug-Eluting Balloon Catheters Product and Services
    • 2.10.4 MicroPort Medical Drug-Eluting Balloon Catheters Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 MicroPort Medical Recent Developments/Updates
  • 2.11 Teleflex
    • 2.11.1 Teleflex Details
    • 2.11.2 Teleflex Major Business
    • 2.11.3 Teleflex Drug-Eluting Balloon Catheters Product and Services
    • 2.11.4 Teleflex Drug-Eluting Balloon Catheters Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Teleflex Recent Developments/Updates

3 Competitive Environment: Drug-Eluting Balloon Catheters by Manufacturer

  • 3.1 Global Drug-Eluting Balloon Catheters Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Drug-Eluting Balloon Catheters Revenue by Manufacturer (2021-2026)
  • 3.3 Global Drug-Eluting Balloon Catheters Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Drug-Eluting Balloon Catheters by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Drug-Eluting Balloon Catheters Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Drug-Eluting Balloon Catheters Manufacturer Market Share in 2025
  • 3.5 Drug-Eluting Balloon Catheters Market: Overall Company Footprint Analysis
    • 3.5.1 Drug-Eluting Balloon Catheters Market: Region Footprint
    • 3.5.2 Drug-Eluting Balloon Catheters Market: Company Product Type Footprint
    • 3.5.3 Drug-Eluting Balloon Catheters Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Drug-Eluting Balloon Catheters Market Size by Region
    • 4.1.1 Global Drug-Eluting Balloon Catheters Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Drug-Eluting Balloon Catheters Consumption Value by Region (2021-2032)
    • 4.1.3 Global Drug-Eluting Balloon Catheters Average Price by Region (2021-2032)
  • 4.2 North America Drug-Eluting Balloon Catheters Consumption Value (2021-2032)
  • 4.3 Europe Drug-Eluting Balloon Catheters Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Drug-Eluting Balloon Catheters Consumption Value (2021-2032)
  • 4.5 South America Drug-Eluting Balloon Catheters Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Drug-Eluting Balloon Catheters Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Drug-Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
  • 5.2 Global Drug-Eluting Balloon Catheters Consumption Value by Type (2021-2032)
  • 5.3 Global Drug-Eluting Balloon Catheters Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Drug-Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
  • 6.2 Global Drug-Eluting Balloon Catheters Consumption Value by Application (2021-2032)
  • 6.3 Global Drug-Eluting Balloon Catheters Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Drug-Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
  • 7.2 North America Drug-Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
  • 7.3 North America Drug-Eluting Balloon Catheters Market Size by Country
    • 7.3.1 North America Drug-Eluting Balloon Catheters Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Drug-Eluting Balloon Catheters Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Drug-Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
  • 8.2 Europe Drug-Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
  • 8.3 Europe Drug-Eluting Balloon Catheters Market Size by Country
    • 8.3.1 Europe Drug-Eluting Balloon Catheters Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Drug-Eluting Balloon Catheters Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Drug-Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Drug-Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Drug-Eluting Balloon Catheters Market Size by Region
    • 9.3.1 Asia-Pacific Drug-Eluting Balloon Catheters Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Drug-Eluting Balloon Catheters Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Drug-Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
  • 10.2 South America Drug-Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
  • 10.3 South America Drug-Eluting Balloon Catheters Market Size by Country
    • 10.3.1 South America Drug-Eluting Balloon Catheters Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Drug-Eluting Balloon Catheters Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Drug-Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Drug-Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Drug-Eluting Balloon Catheters Market Size by Country
    • 11.3.1 Middle East & Africa Drug-Eluting Balloon Catheters Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Drug-Eluting Balloon Catheters Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Drug-Eluting Balloon Catheters Market Drivers
  • 12.2 Drug-Eluting Balloon Catheters Market Restraints
  • 12.3 Drug-Eluting Balloon Catheters Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Drug-Eluting Balloon Catheters and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Drug-Eluting Balloon Catheters
  • 13.3 Drug-Eluting Balloon Catheters Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Drug-Eluting Balloon Catheters Typical Distributors
  • 14.3 Drug-Eluting Balloon Catheters Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Drug-Eluting Balloon Catheters market size was valued at US$ 1564 million in 2025 and is forecast to a readjusted size of US$ 3556 million by 2032 with a CAGR of 12.3% during review period.
    Drug-eluting balloon catheters (often referred to as drug-coated balloon catheters, DCB) are endovascular angioplasty balloons coated with an antiproliferative drug plus an excipient/carrier system. During angioplasty, they deliver mechanical lumen gain while rapidly transferring drug into the vessel wall to inhibit neointimal hyperplasia and reduce restenosis and repeat interventions. The strategic concept is “leave nothing behind,” avoiding the long-term burden of permanent implants and enabling flexible future treatment options, increasingly integrated with lesion-preparation tools and intravascular imaging to support more refined vascular repair.In 2025, global Drug-eluting balloon catheters production reached approximately1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
    Growth is driven by two structural forces: a shift from implant-centric to repair-centric care, where DCBs address restenosis and reintervention pain points with a “leave nothing behind” proposition; and a clearer evidence/regulatory boundary that improves hospital-level adoption confidence. The FDA’s updated assessment on paclitaxel-coated devices for PAD strengthens predictability around long-term safety considerations. Meanwhile, leading medtech companies continue to position DCB portfolios as a contributor to peripheral/vascular growth in annual reporting, signaling an evolution from an adjunct option toward a more standardized toolset.
    The hurdle is scaling with reproducibility and compliance. As drug-device combination products, DCBs are highly sensitive to coating integrity, particulate control, dose consistency, and stability—where process drift can translate into outsized clinical and access risk. In parallel, cost containment and procurement reforms elevate quality systems, supply assurance, and cost efficiency as decisive differentiators. In China, national-level centralized procurement and published outcomes accelerate a more rules-based, scale-driven competitive phase.
    Demand is consolidating around repeatable techniques and bundled solutions. Hospitals increasingly prioritize lower repeat interventions, pathway efficiency, and stable long-term outcomes—driving more routine combination of DCBs with lesion preparation tools, specialty balloons, and intravascular imaging (IVUS/OCT). In peripheral and dialysis access settings where recurrence is common, the preference to avoid repeat implants and preserve future options further reinforces the “leave nothing behind” value narrative.
    Upstream advantage is defined by integrated “materials-coating-validation” capability rather than a simple bill of materials. Key inputs include balloon/catheter polymers and reinforcements, drug APIs (paclitaxel or limus agents) and excipient systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Because requirements on biocompatibility and change control are stringent, medical-grade traceability, clean manufacturing, and robust change management at the supplier level directly shape yield, release consistency, and global compliance efficiency for OEMs.
    This report is a detailed and comprehensive analysis for global Drug-Eluting Balloon Catheters market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Drug-Eluting Balloon Catheters market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Drug-Eluting Balloon Catheters market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Drug-Eluting Balloon Catheters market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Drug-Eluting Balloon Catheters market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Drug-Eluting Balloon Catheters
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Drug-Eluting Balloon Catheters market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Drug-Eluting Balloon Catheters market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Coronary Artery Disease Drug-Eluting Balloon Catheters
    Peripheral Vascular Disease Drug-Eluting Balloon Catheters
    Market segment by Use Scenario
    In-Stent Restenosi
    De Novo
    Small Vessel
    Market segment by Balloon Platform Mechanics
    Semi-/Compliant
    Non-compliant
    Other
    Market segment by Application
    Hospitals and Clinics
    Ambulatory Surgical Centers
    Catheterization Laboratories
    Major players covered
    B. Braun
    Medtronic
    Boston Scientific
    BD
    Yinyi Biotechnology
    Acotec
    Philips
    Lepu Medical
    Eurocor
    MicroPort Medical
    Teleflex
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Drug-Eluting Balloon Catheters product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Drug-Eluting Balloon Catheters, with price, sales quantity, revenue, and global market share of Drug-Eluting Balloon Catheters from 2021 to 2026.
    Chapter 3, the Drug-Eluting Balloon Catheters competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Drug-Eluting Balloon Catheters breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Drug-Eluting Balloon Catheters market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Drug-Eluting Balloon Catheters.
    Chapter 14 and 15, to describe Drug-Eluting Balloon Catheters sales channel, distributors, customers, research findings and conclusion.

    Buy now